Medical Director
Some Typical Challenges |
How IRIS can help |
Resources stretched too thin |
Tools to prioritise projects across all therapeutic areas/business units |
Lack of clarity on project priorities |
Ready access to project priorities across all therapeutic areas/business units |
Meeting launch readiness expectations |
Clearly defined process for product launches (i.e. New Indication, Line Extension, New Chemical Entity etc.) |
Focusing clinical trials programme on high priority launches |
Visibility and tracking of all milestones from study startup to close-out |
Risk of low compliance and frustrating manual process of promotional material approval |
Up to 66% reduction in promotional material approval whilst ensuring high compliance |
The IRIS Advantage
- Deliver more effective, higher quality and trouble-free product launches with ease
- Improve management of Executive team expectations
- Manage Global expectations on Clinical Trial performance
- Managing and tracking turnaround time for Regulatory submissions
- Ensure resources are working effectively on the right projects